Chondrosarcomas revisited

Orthopedics

Volumn 35, Issue 3, 2012, Pages

  Mavrogenis, Andreas F ^a   Gambaroti, Marco ^b   Angelini, Andrea ^b   Palmerini, Emanuela ^b   Staals, Eric L ^b   Ruggieri, Pietro ^b   Papagelopoulos, Panayiotis J ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTINEOPLASTIC AGENT; APOMAB; DASATINIB; DEPSIPEPTIDE; DOXORUBICIN; GEMCITABINE; IMATINIB; MINODRONIC ACID; MONOCLONAL ANTIBODY; PEMETREXED; PERIFOSINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN BCL 2; RAZOXANE; SONIC HEDGEHOG PROTEIN; TRIPARANOL; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ARTICLE; BONE RADIOGRAPHY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CHONDROSARCOMA; CLEAR CELL CHONDROSARCOMA; COMPUTER ASSISTED TOMOGRAPHY; DEDIFFERENTIATED CHONDROSARCOMA; DISTANT METASTASIS; HUMAN; LUNG METASTASIS; MALIGNANT TRANSFORMATION; MESENCHYME CHONDROSARCOMA; METASTASIS FREE SURVIVAL; MYXOID CHONDROSARCOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PERIOSTEAL CHONDROSARCOMA; PRIMARY CHONDROSARCOMA; PROGNOSIS; PROTON THERAPY; RECURRENCE RISK; SECONDARY CHONDROSARCOMA; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR RECURRENCE; TUMOR VASCULARIZATION;

BONE NEOPLASMS; CHONDROSARCOMA; HUMANS; TREATMENT OUTCOME;

EID: 84858640801     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20120222-30     Document Type: Article

References (131)

1. Lee FY, Mankin HJ, Fondren G, et al. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am. 1999; 81(3):326-338. (Pubitemid 29153210)
2. Rizzo M, Ghert MA, Harrelson JM, Scully SP. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. Clin Orthop Relat Res. 2001; (391):224-233. (Pubitemid 32954068)
3. Björnsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ. Primary chondrosarcoma of long bones and limb girdles. Cancer. 1998; 83(10):2105-2119. (Pubitemid 28525392)
4. Ogose A, Unni KK, Swee RG, May GK, Rowland CM, Sim FH. Chondrosarcoma of small bones of the hands and feet. Cancer. 1997; 80(1):50-59. (Pubitemid 27270919)
5. Huvos HG, Marcove RC. Chondrosarcoma in the young. A clinicopathologic analysis of 79 patients younger than 21 years of age. Am J Surg Pathol. 1987; 11(12):930-942. (Pubitemid 18011644)
6. Unni KK. Chondrosarcoma. In: Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases. 5th ed. Philadelphia, PA: Lippincott-Raven; 1996:71-108.
7. Rosenthal DI, Schiller AL, Mankin HJ. Chondrosarcoma: correlation of radiological and histological grade. Radiology. 1984; 150(1):21-26. (Pubitemid 14212270)
8. Healey JH, Lane JM. Chondrosarcoma. Clin Orthop Relat Res. 1986; (204):119-129.
9. Ollivier L, Vanel D, Leclère J. Imaging of chondrosarcomas. Cancer Imaging. 2003; 4(1):36-38.
10. Varma DG, Ayala AG, Carrasco CH, Guo SQ, Kumar R, Edeiken J. Chondrosarcoma: MR imaging with pathologic correlation. Radiographics. 1992; 12(4):687-704.
11. Bertoni F, Bacchini P, Hogendoorn PCW. Chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours of Soft Tissue and Bone. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:247-258.
12. Geimaerdt MJA, Hermans J, Bloem JL, et al. Usefulness of radiography in differentiating enchondroma from central grade I chondrosarcoma. AJR Am J Roentgenol. 1997; 169(4):1097-1104. (Pubitemid 27406912)
13. Murphey MD, Flemming DJ, Boyea SR, Bojescul JA, Sweet DE, Temple HT. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. 1998; 18(5):1213-1237. (Pubitemid 128466884)
14. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977; 40(2):818-831. (Pubitemid 8177905)
15. Lichtenstein L, Jaffe HL. Chondrosarcoma of bone. Am J Pathol. 1943; 19(4):553-589.
16. Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) study group. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones. J Bone Joint Surg Am. 2007; 89(10):2113-2123.
17. Wuisman PI, Jutte PC, Ozaki T. Secondary chondrosarcoma in osteochondromas: medullary extension in 15 of 45 cases. Acta Orthop Scand. 1997; 68(4):396-400. (Pubitemid 27397251)
18. Pierz KA, Stieber JR, Kusumi K, Dormans JP. Hereditary multiple exostoses: one center's experience and review of etiology. Clin Orthop Relat Res. 2002; (401):49-59. (Pubitemid 34832836)
19. Ahmed AR, Tan TS, Unni KK, Collins MS, Wenger DE, Sim FH. Secondary chondrosarcoma in osteochondroma: report of 107 patients. Clin Orthop Relat Res. 2003; (411):193-206. (Pubitemid 36667278)
20. Schwartz HS, Zimmerman NB, Simon MA, Wroble RR, Millar EA, Bonfiglio M. The malignant potential of enchondromatosis. J Bone Joint Surg Am. 1987; 69(2):269-274. (Pubitemid 17026026)
21. Liu J, Hudkins PG, Swee RG, Unni KK. Bone sarcomas associated with Ollier's disease. Cancer. 1987; 59(7):1376-1385. (Pubitemid 17035488)
22. Brien EW, Mirra JM, Kerr R. Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. I. The intramedullary cartilage tumors. Skeletal Radiol. 1997; 26(6):325-353. (Pubitemid 27281367)
23. Mavrogenis AF, Papagelopoulos PJ, Soucacos PN. Skeletal osteochondromas revisited. Orthopedics. 2008; 31(10). orthosupersite.com/view.asp?rID=32071.
24. Mavrogenis AF, Skarpidi E, Papakonstantinou O, Papagelopoulos PJ. Chondrosarcoma in metachondromatosis: a case report. J Bone Joint Surg Am. 2010; 92(6):1507-1513.
25. Bovée JV, Sciot R, Dal Cin P, et al. Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol. 2001; 10(4):228-235. (Pubitemid 33123931)
26. Mandahl N, Gustafson P, Mertens F, et al. Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosomes Cancer. 2002; 33(2):188-200. (Pubitemid 34052500)
27. Nojima T, Unni KK, McLeod RA, Pritchard DJ. Periosteal chondroma and periosteal chondrosarcoma. Am J Surg Pathol. 1985; 9(9):666-677. (Pubitemid 16196281)
28. Dorfman HD, Czerniak B, eds. Bone Tumors. St Louis, MO: Mosby; 1998.
29. Boriani S, Bacchini P, Bertoni F, Campanacci M. Periosteal chondroma. A review of twenty cases. J Bone Joint Surg Am. 1983; 65(2):205-212. (Pubitemid 13142118)
30. Bertoni F, Boriani S, Laus M, Campanacci M. Periosteal chondrosarcoma and periosteal osteosarcoma. Two distinct entities. J Bone Joint Surg Br. 1982; 64(3):370-376. (Pubitemid 12003172)
31. Robinson P, White LM, Sundaram M, et al. Periosteal chondroid tumors: radiologic evaluation with pathologic correlation. AJR Am J Roentgenol. 2001; 177(5):1183-1188. (Pubitemid 32995564)
32. Vanel D, De Paolis M, Monti C, Mercuri M, Picci P. Radiological features of 24 periosteal chondrosarcomas. Skeletal Radiol. 2001; 30(4):208-212. (Pubitemid 32396702)
33. Schajowicz F. Juxtacortical chondrosarcoma. J Bone Joint Surg Br. 1977; 59(4):473-480. (Pubitemid 8223407)
34. Papagelopoulos PJ, Galanis EC, Mavrogenis AF, et al. Survivorship analysis in patients with periosteal chondrosarcoma. Clin Orthop Relat Res. 2006; 448:199-207. (Pubitemid 44324870)
35. Ayoub KS, Grimer RJ, Carter SR, Mangham DC, Davies AM, Tillman RM. Clear cell chondrosarcoma of bone. Sarcoma. 1999; 3(2):115-119. (Pubitemid 29484564)
36. Present D, Bacchini P, Pignatti G, Picci P, Bertoni F, Campanacci M. Clear cell chondrosarcoma of bone. A report of 8 cases. Skeletal Radiol. 1991; 20(3):187-191.
37. Bjornsson J, Unni KK, Dahlin DC, Beabout JW, Sim FH. Clear cell chondrosarcoma of bone. Observations in 47 cases. Am J Surg Pathol. 1984; 8(3):223-230. (Pubitemid 14166775)
38. Ishida T, Yamamoto M, Goto T, Kawano H, Yamamoto A, Machinami R. Clear cell chondrosarcoma of the pelvis in a skeletally immature patient. Skeletal Radiol. 1999; 28(5):290-293. (Pubitemid 29299034)
39. Kalil RK, Inwards CY, Unni KK, et al. Dedifferentiated clear cell chondrosarcoma. Am J Surg Pathol. 2000; 24(8):1079-1086. (Pubitemid 30612829)
40. Donati D, Yin JQ, Colangeli M, et al. Clear cell chondrosarcoma of bone: long time follow-up of 18 cases [published online ahead of print May 24, 2007]. Arch Orthop Trauma Surg. 2008; 128(2):137-142. (Pubitemid 351167206)
41. Antonescu CR, Argani P, Erlandson RA, Healey JH, Ladanyi M, Huvos AG. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study. Cancer. 1998; 83:1504-1521. (Pubitemid 28465468)
42. Keel SB, Bhan AK, Liebsch NJ, Rosenberg AE. Chondromyxoid fibroma of the skull base: a tumor which may be confused with chordoma and chondrosarcoma. A report of three cases and review of the literature. Am J Surg Pathol. 1997; 21(5):577-582.
43. Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC. Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer. 1986; 57(12):2444-2453. (Pubitemid 16118989)
44. Dabska M, Huvos AG. Mesenchymal chondrosarcoma in the young. Virchows Arch A Pathol Anat Histopathol. 1983; 399(1):89-104.
45. Huvos AG, Rosen G, Dabska M, Marcove RC. Mesenchymal chondrosarcoma. A clinicopathologic analysis of 35 patients with emphasis on treatment. Cancer. 1983; 51(7):1230-1237. (Pubitemid 13161100)
46. Vencio EF, Reeve CM, Unni KK, Nascimento AG. Mesenchymal chondrosarcoma of the jaw bones: clinicopathologic study of 19 cases. Cancer. 1998; 82(12):2350-2355. (Pubitemid 28283441)
47. Bertoni F, Picci P, Bacchini P, et al. Mesenchymal chondrosarcoma of bone and soft tissues. Cancer. 1983; 52(3):533-541. (Pubitemid 13073483)
48. Harwood AR, Krajbich JI, Fornasier VL. Mesenchymal chondrosarcoma: a report of 17 cases. Clin Orthop Relat Res. 1981; (158):144-148. (Pubitemid 11040627)
49. Lockhart R, Menard P, Martin JP, Auriol M, Vaillant JM, Bertrand JC. Mesenchymal chondrosarcoma of the jaws. Report of four cases. Int J Oral Maxillofac Surg. 1998; 27(5):358-362. (Pubitemid 128361534)
50. Hoang MP, Suarez PA, Donner LR, et al. Mesenchymal chondrosarcoma: a small cell neoplasm with polyphenotypic differentiation. Int J Surg Pathol. 2000; 8(4):291-301. (Pubitemid 32120691)
51. Swanson PE, Lillemoe TJ, Manivel JC, Wick MR. Mesenchymal chondrosarcoma. An immunohistochemical study. Arch Pathol Lab Med. 1990; 114(9):943-948. (Pubitemid 20265289)
52. Frassica FJ, Unni KK, Beabout JW, Sim FH. Dedifferentiated chondrosarcoma. A report of the clinicopathological features and treatment of seventy-eight cases. J Bone Joint Surg Am. 1986; 68(8):1197-1205. (Pubitemid 17198797)
53. Staals EL, Bacchini P, Bertoni F. Dedifferentiated central chondrosarcoma. Cancer. 2006; 106(12):2682-2691.
54. Mitchell AD, Ayoub K, Mangham DC, Grimer RJ, Carter SR, Tillman RM. Experience in the treatment of dedifferentiated chondrosarcoma. J Bone Joint Surg Am. 2000; 82(1):55-61. (Pubitemid 30060127)
55. Mercuri M, Picci P, Campanacci L, Rulli E. Dedifferentiated chondrosarcoma. Skeletal Radiol. 1995; 24(6):409-416.
56. Dahlin DC, Beabout JW. Dedifferentiation of low-grade chondrosarcomas. Cancer. 1971; 28(2):461-466.
57. Sopta J, Dordević A, Tulić G, Mijucić V. Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases [published online ahead of print July 25, 2007]. J Cancer Res Clin Oncol. 2008; 134(2):147-152. (Pubitemid 350234058)
58. Munk PL, Connell DG, Quenville NF. Dedifferentiated chondrosarcoma of bone with leiomyosarcomatous mesenchymal component: a case report. Can Assoc Radiol J. 1988; 39(3):218-220.
59. Estrada EG, Ayala AG, Lewis V, Czerniak B. Dedifferentiated chondrosarcoma with a noncartilaginous component mimicking a conventional giant cell tumor of bone. Ann Diagn Pathol. 2002; 6(3):159-163. (Pubitemid 34700853)
60. Staals EL, Bacchini P, Mercuri M, Bertoni F. Dedifferentiated chondrosarcomas arising in preexisting osteochondromas. J Bone Joint Surg Am. 2007; 89(5):987-993. (Pubitemid 46724588)
61. Kumta SM, Griffith JF, Chow LT, Leung PC. Primary juxtacortical chondrosarcoma dedifferentiating after 20 years. Skeletal Radiol. 1998; 27(10):569-573. (Pubitemid 28505164)
62. Capanna R, Bertoni F, Bettelli G, et al. Dedifferentiated chondrosarcoma. J Bone Joint Surg Am. 1988; 70(1):60-69. (Pubitemid 18054893)
63. Daly PJ, Sim FH, Wold LE. Dedifferentiated chondrosarcoma of bone. Orthopedics. 1989; 12(5):763-767.
64. de Lange EE, Pope TL Jr, Fechner RE. Dedifferentiated chondrosarcoma: radiographic features. Radiology. 1986; 161(2):489-492. (Pubitemid 17179958)
65. Riedel RF, Larrier N, Dodd L, Kirsch D, Martinez S, Brigman BE. The clinical management of chondrosarcoma [published online ahead of print February 24, 2009]. Curr Treat Options Oncol. 2009; 10(1-2):94-106.
66. Fiorenza F, Abudu A, Grimer RJ, et al. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg Br. 2002; 84(1):93-99. (Pubitemid 34105631)
67. Dickey ID, Rose PS, Fuchs B, et al. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg Am. 2004; 86(11):2412-2418. (Pubitemid 39473080)
68. Bruns J, Elbracht M, Niggemeyer O. Chondrosarcoma of bone: an oncological and functional follow-up study. Ann Oncol. 2001; 12(6):859-864. (Pubitemid 32655099)
69. Pring ME, Weber KL, Unni KK, Sim FH. Chondrosarcoma of the pelvis. A review of sixty-four cases. J Bone Joint Surg Am. 2001; 83(11):1630-1642.
70. Donati D, El Ghoneimy A, Bertoni F, Di Bella C, Mercuri M. Surgical treatment and outcome of conventional pelvic chondrosarcoma. J Bone Joint Surg Br. 2005; 87(11):1527-1530. (Pubitemid 41723098)
71. Leerapun T, Hugate RR, Inwards CY, Scully SP, Sim FH. Surgical management of conventional grade I chondrosarcoma of long bones. Clin Orthop Relat Res. 2007; 463:166-172. (Pubitemid 47585267)
72. Normand AN, Cannon CP, Lewis VO, Lin PP, Yasko AW. Curettage of biopsy-diagnosed grade 1 periacetabular chondrosarcoma. Clin Orthop Relat Res. 2007; 459:146-149. (Pubitemid 46878208)
73. Van Der Geest IC, Servaes P, Schreuder HW, et al. Chondrosarcoma of bone: functional outcome and quality of life. J Surg Oncol. 2002; 81(2):70-74.
74. Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008; 13(3):320-329. (Pubitemid 351679908)
75. Wyman JJ, Hornstein AM, Meitner PA, et al. Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance. J Orthop Res. 1999; 17(6):935-940.
76. Grimer RJ, Gosheger G, Taminiau A, et al. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group [published online ahead of print August 27, 2007]. Eur J Cancer. 2007; 43(14):2060-2065. (Pubitemid 47380361)
77. Nooij MA, Whelan J, Bramwell VH, et al. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. Eur J Cancer. 2005; 41(2):225-230. (Pubitemid 40126954)
78. Southwest Oncology Group. Pemetrexed Disodium in treating patients with recurrent and unresectable or metastatic chondrosarcoma. http://clinicaltrials. gov/ct2/show/NCT00107419. Accessed December 2007.
79. National Cancer Institute (NCI). Gemcitabine and docetaxel in treating patients with recurrent osteosarcoma (closed to accrual as of 12/21/06) or Ewing's sarcoma or unresectable or locally recurrent chondrosarcoma. http://clinicaltrials.gov/ct2/show/NCT00073983. Accessed January 2008.
80. Moussavi-Harami F, Mollano A, Martin JA, et al. Intrinsic radiation resistance in human chondrosarcoma cells [published online ahead of print June 5, 2006]. Biochem Biophys Res Commun. 2006; 346(2):379-385. (Pubitemid 43902698)
81. Kim DW, Seo SW, Cho SK, et al. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells. J Orthop Res. 2007; 25(6):820-828. (Pubitemid 46831891)
82. Rhomberg W, Eiter H, Böhler F, Dertinger S. Combined radiotherapy and razoxane in the treatment of chondrosarcomas and chordomas. Anticancer Res. 2006; 26(3B):2407-2411. (Pubitemid 43980209)
83. Hasegawa T, Ishii D, Kida Y, Yoshimoto M, Koike J, Iizuka H. Gamma knife surgery for skull base chordomas and chondrosarcomas. J Neurosurg. 2007; 107(4):752-757. (Pubitemid 47547738)
84. Martin JJ, Niranjan A, Kondziolka D, Flickinger JC, Lozanne KA, Lunsford LD. Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg. 2007; 107(4):758-764. (Pubitemid 47547739)
85. McLoughlin GS, Sciubba DM, Wolinsky JP. Chondroma/chondrosarcoma of the spine. Neurosurg Clin N Am. 2008; 19(1):57-63. (Pubitemid 350296960)
86. Mazeron JJ, Noel G, Feuvret L, Calugaru V, Racadot S. Clinical complementarities between proton and carbon therapies. Radiother Oncol. 2004; 73 suppl 2:S50-S52. (Pubitemid 41219113)
87. Hug EB, Slater JD. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am. 2000; 11(4):627-638.
88. Schulz-Ertner D, Nikoghosyan A, Hof H, et al. Carbon ion radiotherapy of skull base chondrosarcomas [published online ahead of print October 23, 2006]. Int J Radiat Oncol Biol Phys. 2007; 67(1):171-177. (Pubitemid 44959492)
89. Lagonigro MS, Tamborini E, Negri T, et al. PDGFRalpha, PDGFRbeta and KIT expression/ activation in conventional chondrosarcoma. J Pathol. 2006; 208(5):615-623.
90. Sulzbacher I, Birner P, Trieb K, Mühlbauer M, Lang S, Chott A. Platelet-derived growth factor-alpha receptor expression supports the growth of conventional chondrosarcoma and is associated with adverse outcome. Am J Surg Pathol. 2001; 25(12):1520-1527. (Pubitemid 33096967)
91. Sarcoma Alliance for Research through Collaboration. Trial of Dasatinib in Advanced Sarcomas. http://clinicaltrials.gov/ct2/show/NCT00464620. Accessed January 2008.
92. Genentech. A study of PRO95780 in patients with advanced chondrosarcoma (APM4171g). http://clinicaltrials.gov/ct2/show/NCT00543712. Accessed December 2007.
93. Chawla S, Demetri G, Desai J, et al. Initial results of a phase II study of the safety and efficacy of the Apomab DR5 agonist antibody in advanced chondrosarcoma and synovial sarcoma patients. Paper presented at: CTOS Annual Meeting; November 12-15, 2008; London, United Kingdom. Abstract 35010.
94. van der Eerden BC, Karperien M, Gevers EF, Löwik CW, Wit JM. Expression of Indian hedgehog, parathyroid hormone-related protein, and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth. J Bone Miner Res. 2000; 15(6):1045-1055. (Pubitemid 30350067)
95. Hopyan S, Gokgoz N, Poon R, et al. A mutant PTH/PTHrP type I receptor in enchondromatosis [published online ahead of print February 19, 2002]. Nat Genet. 2002; 30(3):306-310.
96. Tiet TD, Hopyan S, Nadesan P, et al. Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. Am J Pathol. 2006; 168(1):321-330. (Pubitemid 43062583)
97. Morrison C, Radmacher M, Mohammed N, et al. MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome. J Clin Oncol. 2005; 23(36):9369-9376.
98. Rozeman LB, Hameetman L, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC, Bovée JV. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas. J Pathol. 2005; 205(4):476-482. (Pubitemid 40361336)
99. Bovée JV, van den Broek LJ, Cleton-Jansen AM, Hogendoorn PC. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondromas towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest. 2000; 80(12):1925-1934.
100. Amling M, Pösl M, Hentz MW, Priemel M, Delling G. PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors. Verh Dtsch Ges Pathol. 1998; 82:160-169.
101. Pateder DB, Gish MW, O'Keefe RJ, Hicks DG, Teot LA, Rosier RN. Parathyroid hormone-related Peptide expression in cartilaginous tumors. Clin Orthop Relat Res. 2002; (403):198-204. (Pubitemid 35168375)
102. Hameetman L, Kok P, Eilers PH, Cleton-Jansen AM, Hogendoorn PC, Bovée JV. The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting [published online ahead of print March 3, 2005]. Virchows Arch. 2005; 446(4):430-437. (Pubitemid 40674851)
103. Miyaji T, Nakase T, Onuma E, et al. Monoclonal antibody to parathyroid hormone-related protein induces differentiation and apoptosis of chondrosarcoma cells. Cancer Lett. 2003; 199(2):147-155. (Pubitemid 37297708)
104. Geirnaerdt MJ, Hogendoorn PC, Bloem JL, Taminiau AH, van der Woude HJ. Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology. 2000; 214(2):539-546. (Pubitemid 30077716)
105. Ayala G, Liu C, Nicosia R, Horowitz S, Lackman R. Microvasculature and VEGF expression in cartilaginous tumors. Hum Pathol. 2000; 31(3):341-346. (Pubitemid 30161353)
106. Kalinski T, Krueger S, Sel S, Werner K, Ropke M, Roessner A. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta. Cancer. 2006; 106(9):2028-2038. (Pubitemid 43673220)
107. Morioka H, Weissbach L, Vogel T, et al. Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin Cancer Res. 2003; 9(3):1211-1217. (Pubitemid 36323731)
108. Sutton KM, Wright M, Fondren G, Towle CA, Mankin HJ. Cyclooxygenase-2 expression in chondrosarcoma. Oncology. 2004; 66(4):275-280. (Pubitemid 38822796)
109. Gouin F, Ory B, Rédini F, Heymann D. Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival. Int J Cancer. 2006; 119(5):980-984. (Pubitemid 44116903)
110. Kubo T, Shimose S, Matsuo T, et al. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells. J Orthop Res. 2006; 24(6):1138-1144. (Pubitemid 43870875)
111. Lai TJ, Hsu SF, Li TM, et al. Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line. Acta Pharmacol Sin. 2007; 28(8):1231-1235.
112. Sakimura R, Tanaka K, Yamamoto S, et al. The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells. Clin Cancer Res. 2007; 13(1):275-282. (Pubitemid 46121880)
113. Nilsson O, Marino R, De Luca F, Phillip M, Baron J. Endocrine regulation of the growth plate [published online ahead of print October 4, 2005]. Horm Res. 2005; 64(4):157-165. (Pubitemid 41642759)
114. Cleton-Jansen AM, van Beerendonk HM, Baelde HJ, Bovée JV, Karperien M, Hogendoorn PC. Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma. Clin Cancer Res. 2005; 11(22):8028-8035. (Pubitemid 41698744)
115. Grifone TJ, Haupt HM, Podolski V, Brooks JJ. Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas. Int J Surg Pathol. 2008; 16(1):31-37.
116. Ozaki T, Lindner N, Hillmann A, Rödl R, Blasius S, Winkelmann W. Influence of intralesional surgery on treatment outcome of chondrosarcoma. Cancer. 1996; 77:1292-1297. (Pubitemid 26102326)
117. Gitelis S, Bertoni F, Picci P, Campanacci M. Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am. 1981; 63(8):1248-1257. (Pubitemid 11022301)
118. Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009; 91(5):1063-1072.
119. Itälä A, Leerapun T, Inwards C, Collins M, Scully SP. An institutional review of clear cell chondrosarcoma. Clin Orthop Relat Res. 2005; 440:209-212. (Pubitemid 41579218)
120. Gengler C, Letovancec I, Taminelli L, Egger JF, Guillou L. Desmin and myogenin reactivity in mesenchymal chondrosarcoma: a potential diagnostic pitfall. Histopathology. 2006; 48(2):201-203.
121. Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007; 459:40-47. (Pubitemid 46878192)
122. Söderström M, Ekfors TO, Böhling TO, Teppo LH, Vuorio EI, Aro HT. No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990. Acta Orthop Scand. 2003; 74(3):344-350. (Pubitemid 36890744)
123. Weber KL, Pring ME, Sim FH. Treatment and outcome of recurrent pelvic chondrosarcoma. Clin Orthop Relat Res. 2002; (397):19-28. (Pubitemid 34442011)
124. Sheth DS, Yasko AW, Johnson ME, Ayala AG, Murray JA, Romsdahl MM. Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery. Cancer. 1996; 78(4):745-750. (Pubitemid 26268604)
125. Schwab JH, Wenger D, Unni K, Sim FH. Does local recurrence impact survival in low-grade chondrosarcoma of the long bones? Clin Orthop Relat Res. 2007; 462:175-180. (Pubitemid 47367860)
126. de Camargo OP, Baptista AM, Atanásio MJ, Waisberg DR. Chondrosarcoma of bone: lessons from 46 operated cases in a single institution. Clin Orthop Relat Res. 2010; 468(11):2969-2975.
127. Henderson ED, Dahlin DC. Chondrosarcoma of bone-a study of two hundred and eighty-eight cases. J Bone Joint Surg Am. 1963; 45:1450-1458.
128. Sanerkin NG, Gallagher P. A review of the behaviour of chondrosarcoma of bone. J Bone Joint Surg Br. 1979; 61(4):395-400. (Pubitemid 10201796)
129. Ucla E, Tomeno B, Forest M. Tumor prognostic factors in chondrosarcoma of the locomotor system. Apropos of 180 cases [in French]. Rev Chir Orthop Reparatrice Appar Mot. 1991; 77(5):301-311.
130. Streitbürger A, Ahrens H, Balke M, et al. Grade I chondrosarcoma of bone: the Münster experience [published online ahead of print October 15, 2008]. J Cancer Res Clin Oncol. 2009; 135(4):543-550.
131. Shives TC, McLeod RA, Unni KK, Schray MF. Chondrosarcoma of the spine. J Bone Joint Surg Am. 1989; 71(8):1158-1165. (Pubitemid 19262364)